Highlights
Allergy/Immunology
Asthma Birth Cohorts: What Have We Learned? The Next Frontier
Asthma Pathogenesis and Therapy: From Bench to Bedside (Postgraduate Course)
Childhood Infectious Origins of Adult Lung Disease
Exosomes and Microvesicles: Markers of Disease or Therapeutic Agents
Implementing the ATS/ERS Severe Asthma Guidelines
Inflammation and Pulmonary Arterial Hypertension
Novel Insights into Targets and Treatment Opportunities in Asthma
Progenitor Cell Programs for Chronic Lung Disease
Pulmonary Vasculitis: New Concepts and Management Strategies in the Era of Biological Therapies
Regulation of Aging in the Lung
The Case for Complementary Therapies: Magical Thinking and Scientific Rationale
Updates in Genomic and Precision Medicine

“The ATS conference is unique in that it positions basic science against a backdrop of translational research addressing unmet clinical needs.”

Andrew Halayko, PhD, Professor of Physiology and Internal Medicine, University of Manitoba